Hollywood Director Makes 575% Profit on Dogecoin Bet Using Diverted Netflix Budget: Report
A Hollywood director named Carl Erik Rinsch allegedly made a massive profit of 575% by trading Dogecoin (DOGE) with funds that were originally reserved for a Netflix show. According to The New York Times, Rinsch received $55 million from Netflix to fund the show “Conquest” between 2020 and 2021. However, disagreements with the company led him to invest millions of dollars in DOGE instead.
The report states that Rinsch’s erratic behavior and failure to meet production milestones caused Netflix to believe that the project could not move forward. As a result, Netflix wrote off the project. After investing in DOGE, Rinsch also made options bets in the stock market and splurged on luxury items such as Rolls Royce vehicles and a Ferrari.
Despite these risky investments, Rinsch’s bet on Dogecoin paid off. He transferred $4 million to Kraken, a crypto exchange, and purchased DOGE worth that amount. In 2021, he sold his holdings for an astounding $27 million. The Times reports that during an online chat with a Kraken representative, Rinsch expressed gratitude and said, “Thank you and God bless crypto.”
Hot Take: Hollywood Director’s Risky Move Results in Massive Dogecoin Profit
Hollywood director Carl Erik Rinsch took a major gamble when he used funds meant for a Netflix show to invest in Dogecoin. Despite disagreements with the streaming service and extravagant spending on luxury items, Rinsch’s bet on DOGE paid off handsomely. He saw a staggering 575% return on his investment, ultimately liquidating his holdings for $27 million.
This story highlights the potential gains and risks associated with cryptocurrency trading. It also demonstrates the unpredictable nature of meme assets like Dogecoin. While Rinsch’s success may inspire others to invest in cryptocurrencies, it’s important to remember that the market can be volatile and unpredictable. Only invest what you can afford to lose and do thorough research before making any investment decisions.
By
By
By
By